Stepan Company (SCL) Q3 2024 earnings summary

Executive summary

• Net income for Q3 2024 was $23.6M ($1.03/diluted share), up 88% year-over-year; adjusted net income was $23.7M, up 61%, driven by higher margins and a lower effective tax rate.

• EBITDA for Q3 2024 was $53.0M, up 18% from $45.1M in Q3 2023; adjusted EBITDA was $53.1M, up 11% from $48.0M.

• Global sales volume declined 1% year-over-year, with double-digit growth in Surfactant end markets offset by weakness in Polymers.

• Free cash flow for the quarter was negative $4.0M, reflecting inventory build for hurricane season and plant turnarounds; year-to-date free cash flow was $7.2M.

• $13.3M in pre-tax cost savings recognized in Q3 as part of a $50M annual cost reduction initiative.

Financial highlights

• Q3 2024 net sales were $546.8M, down 3% year-over-year, impacted by lower prices, volume, and foreign currency translation.

• Q3 2024 gross profit was $75.7M (up from $71.2M); operating income was $23.9M (up from $19.5M); diluted EPS was $1.03 (up from $0.55).

• Surfactant net sales grew 2% to $382.7M; volume up 3% year-over-year; operating income up 71% to $26.3M.

• Polymer net sales declined 12% to $149.8M; volume down 11%; operating income down 30% to $15.2M.

• Specialty Products net sales fell 24% to $14.3M, but operating income rose 55% to $3.7M and adjusted EBITDA up 33%.

Outlook and guidance

• Management expects continued adjusted EBITDA growth and positive free cash flow for the full year, supported by Surfactant volume growth and Pasadena plant completion.

• Rigid Polyol demand is expected to improve as macroeconomic and interest rate conditions stabilize in 2025.

• Capital expenditures for 2024 are projected at $120M–$125M, including Pasadena completion.

• Free cash flow is expected to improve with Pasadena investment completion and ongoing cost reductions.

• No formal EBITDA guidance, but $60M quarterly EBITDA seen as achievable as one-time impacts subside.